Grace Oluwatoyin Mensah-Agyei
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Grace Oluwatoyin Mensah-Agyei has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Seyi Samson Enitan
Department of Medical Laboratory Science, Babcock University, Ilishan-Remo, Ogun State, Nigeria
3 shared publications - Grace Eleojo Itodo
Department of Microbiology, Federal Teaching Hospital, Lokoja, Kogi State, Nigeria
2 shared publications - Richard Akele
Department of Biomedical Science, School of Applied Science, University Of Brighton, London, United Kingdom
2 shared publications - Ajibade Oluwatosin
Adeleke University
1 shared publication - Akeredolu Abosede Abolanle
Department of Medical Microbiology, Babcock University, Ilishan-Remo, Ogun State, Nigeria
1 shared publication - Akpan Nevillah Nice
Department of Microbiology, Babcock University, Ilishan-Remo, Ogun State, Nigeria
1 shared publication
Latest Publications
- Open Access
- 28 May 2026
- Published by Springer Nature in Research Square
Imipenem Resistance: A Clarion Call to Antibiotic Stewardship
Background Imipenem, a carbapenem antibiotic with a broader antimicrobial spectrum and greater potency than other beta-lactam antibiotics, has been considered a last-resort antibiotic for severe Gram-negative infections. However, escalating resistance now threatens its clinical utility worldwide. This review synthesizes current knowledge on the epidemiology, molecular mechanisms, and therapeutic challenges associated with imipenem resistance in clinically significant pathogens such as Klebsiella pneumoniae , Escherichia coli, Pseudomonas aeruginosa , and Acinetobacter baumannii . Resistance arises through diverse pathways—including carbapenemase production, porin loss, efflux pump overexpression, and synergistic mutations—that collectively diminish drug efficacy and complicate treatment. Methods A systematic literature search was conducted across four major electronic databases — PubMed, Scopus, ScienceDirect, and Google Scholar — to identify relevant publications on imipenem resistance, carbapenem resistance mechanisms, clinical outcomes, and antibiotic stewardship interventions. Sixty-six publications met the inclusion criteria. Results Therapeutic options remain limited, often relying on toxic or suboptimal agents such as colistin, while emerging alternatives—including β-lactam/β-lactamase inhibitor combinations, cefiderocol, antimicrobial peptides, bacteriophages, and immunomodulatory approaches—show promise but are not yet universally accessible. Effective management therefore requires integration of precision diagnostics, antimicrobial stewardship, and infection prevention strategies to optimize therapy and contain transmission. Conclusion Coordinated action across bedside practice, hospital policy, and global health governance is essential to preserve existing therapies and accelerate the development of sustainable alternatives. Without decisive intervention, the continued rise of imipenem resistance may herald a post-antibiotic era in which even routine infections become untreatable.
- 28 May 2026
- Published by Springer Nature in Research Square
Open AccessImipenem Resistance: A Clarion Call to Antibiotic Stewardship
Background Imipenem, a carbapenem antibiotic with a broader antimicrobial spectrum and greater potency than other beta-lactam antibiotics, has been considered a last-resort antibiotic for severe Gram-negative infections. However, escalating resistance now threatens its clinical utility worldwide. This review synthesizes current knowledge on the epidemiology, molecular mechanisms, and therapeutic challenges associated with imipenem resistance in clinically significant pathogens such as Klebsiella pneumoniae , Escherichia coli, Pseudomonas aeruginosa , and Acinetobacter baumannii . Resistance arises through diverse pathways—including carbapenemase production, porin loss, efflux pump overexpression, and synergistic mutations—that collectively diminish drug efficacy and complicate treatment. Methods A systematic literature search was conducted across four major electronic databases — PubMed, Scopus, ScienceDirect, and Google Scholar — to identify relevant publications on imipenem resistance, carbapenem resistance mechanisms, clinical outcomes, and antibiotic stewardship interventions. Sixty-six publications met the inclusion criteria. Results Therapeutic options remain limited, often relying on toxic or suboptimal agents such as colistin, while emerging alternatives—including β-lactam/β-lactamase inhibitor combinations, cefiderocol, antimicrobial peptides, bacteriophages, and immunomodulatory approaches—show promise but are not yet universally accessible. Effective management therefore requires integration of precision diagnostics, antimicrobial stewardship, and infection prevention strategies to optimize therapy and contain transmission. Conclusion Coordinated action across bedside practice, hospital policy, and global health governance is essential to preserve existing therapies and accelerate the development of sustainable alternatives. Without decisive intervention, the continued rise of imipenem resistance may herald a post-antibiotic era in which even routine infections become untreatable.
- Open Access
- 14 October 2024
- Published by Egyptian Knowledge Bank in Afro-Egyptian Journal of Infectious and Endemic Diseases
Prevalence of Chikungunya Virus IgG and IgM Antibodies among Febrile Patients Presumptively Diagnosed with Malaria in Ogun State, Nigeria
Background and study aim: In Nigeria, there is paucity of information on the epidemiology of infections due to Chikungunya virus (CHIKV) especially among patients with febrile illness. Cases of febrile illness are usually associated with malaria and typhoid fever without considering the possibility of viral aetiology. The aim of the study was to determine the prevalence and associated risk factors of CHIKV infections among febrile illness presumptively diagnosed of malaria in Ogun State, Nigeria. Patients and Methods: A total of 165 patients (94 females and 71 males) were recruited for the study. The presence of malarial parasite was determined by microscopic examination of blood films. Sera were tested for presence of CHIKV immunoglobin (Ig) IgM and IgG antibodies using CHIKV rapid diagnostic test kit. Results: Out of the 165 patients screened, 102 (61.8%) were positive for malarial parasite, 18 (10.9%), 5 (3.0%) and 4 (2.4%) were positive for the presence of CHIKV IgM Ab only, CHIKV IgG Ab only, and both, respectively. A statistically significant association was observed between CHIKV IgM antibody positivity and malaria. Participants who tested positive for CHIKV IgG antibody only were all negative for malaria. Meanwhile, participants positive for both CHIKV IgM and IgG antibodies did not test positive for malaria. Lack of knowledge of CHIKV, presence of mosquitos in the environment, presence of stagnant water sources around, lack of routine medical check-ups and self-medication practices are some of the risk factors identified in this study. Conclusion: The findings underscore the importance of considering CHIKV infection alongside malaria in febrile patients, particularly in malaria-endemic regions.
- 14 October 2024
- Published by Egyptian Knowledge Bank in Afro-Egyptian Journal of Infectious and Endemic Diseases
Open AccessPrevalence of Chikungunya Virus IgG and IgM Antibodies among Febrile Patients Presumptively Diagnosed with Malaria in Ogun State, Nigeria
Background and study aim: In Nigeria, there is paucity of information on the epidemiology of infections due to Chikungunya virus (CHIKV) especially among patients with febrile illness. Cases of febrile illness are usually associated with malaria and typhoid fever without considering the possibility of viral aetiology. The aim of the study was to determine the prevalence and associated risk factors of CHIKV infections among febrile illness presumptively diagnosed of malaria in Ogun State, Nigeria. Patients and Methods: A total of 165 patients (94 females and 71 males) were recruited for the study. The presence of malarial parasite was determined by microscopic examination of blood films. Sera were tested for presence of CHIKV immunoglobin (Ig) IgM and IgG antibodies using CHIKV rapid diagnostic test kit. Results: Out of the 165 patients screened, 102 (61.8%) were positive for malarial parasite, 18 (10.9%), 5 (3.0%) and 4 (2.4%) were positive for the presence of CHIKV IgM Ab only, CHIKV IgG Ab only, and both, respectively. A statistically significant association was observed between CHIKV IgM antibody positivity and malaria. Participants who tested positive for CHIKV IgG antibody only were all negative for malaria. Meanwhile, participants positive for both CHIKV IgM and IgG antibodies did not test positive for malaria. Lack of knowledge of CHIKV, presence of mosquitos in the environment, presence of stagnant water sources around, lack of routine medical check-ups and self-medication practices are some of the risk factors identified in this study. Conclusion: The findings underscore the importance of considering CHIKV infection alongside malaria in febrile patients, particularly in malaria-endemic regions.
- Open Access
- 18 October 2022
- Published by SASPR Edu International Pvt. Ltd in Scholars International Journal of Traditional and Complementary Medicine
- Vol. 5 (9) , 175-183
Phytochemical Screening, Proximate Analysis and Microbiological Quality of Bio-Clean II Herbal Remedy
- 18 October 2022
- Published by SASPR Edu International Pvt. Ltd in Scholars International Journal of Traditional and Complementary Medicine
- Vol. 5 (9) , 175-183
Open AccessPhytochemical Screening, Proximate Analysis and Microbiological Quality of Bio-Clean II Herbal Remedy